Talk:Apatinib
This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||
|
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Apatinib.
|
External links modified
[edit]Hello fellow Wikipedians,
I have just modified one external link on Apatinib. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
- Added archive https://web.archive.org/web/20110713235112/http://www.lskbiopartners.com/new_site2008/sub03_01.htm to http://www.lskbiopartners.com/new_site2008/sub03_01.htm
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}}
(last update: 5 June 2024).
- If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
- If you found an error with any archives or the URLs themselves, you can fix them with this tool.
Cheers.—InternetArchiveBot (Report bug) 22:35, 7 July 2017 (UTC)
new non-proprietary name and image corrections
[edit]I've found a couple things that need to be edited for this page - I'm not sure how to do this:
1) AMA-USAN and WHO-INN have officially designated the non-proprietary name of apatinib to be "rivoceranib".
http://lskbiopharma.com/lskb-announces-official-nonproprietary-naming-of-apatinib-yn968d1-rivoceranib/ https://searchusan.ama-assn.org/finder/usan/search/RIVOCERANIB/relevant/1/
Does this need to be set up as a separate page? apatinib is still the 'common name' - but there is no page for rivoceranib. Or does this page just refer to the official non-proprietary name?
2) The chemical structure image and the 3d chemical structure image are incorrect - I am not sure how to upload an image if I do not have the rights - The correct images can be found by clicking on the PubChem CID link:
https://pubchem.ncbi.nlm.nih.gov/compound/45139106 https://pubchem.ncbi.nlm.nih.gov/compound/45139106#section=2D-Structure
thanks for the assistance 68windmills (talk) 22:49, 21 March 2018 (UTC)
Incorrect structure of Apatinib
[edit]It appears to me that the structure and IUPAC name of Apatinib are incorrect.
The IUPAC name at least misses a closing ] and might not reflect the correct structure.
The bottom pyridyl ring does not contain a methyl group but is connected to the rest of the molecule with a CH2. — Preceding unsigned comment added by 192.87.23.66 (talk) 09:40, 10 April 2018 (UTC)